clinical trial · NCT05752032
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo
ICM Co. Ltd.·—·enrolling by invitation·n = 16
Osteoarthritis, KneeICM-203Placebo
brief summary
This is an observational study of the long term safety and efficacy of ICM-203.
started
Mar 16, 2023
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
Mar 27, 2026
detailed description
Subjects who have received ICM-203 or matching placebo from ICM-203 clinical studies will be enrolled. Subjects will be contacted annually to collect safety and efficacy outcomes until 5 years after the last dose of ICM-203 or placebo.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol